STAA
Staar Surgical Co.
Halal Rating :
Last Price
$22.25
Last updated:
Market Cap
-
7D Change
-1.02%
1 Year Change
-25.11%
Company Overview
Industries
Exchange
Next Earnings Date
STAAR Surgical Company develops, manufactures, and markets implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company's primary product is the EVO Visian ICL (Implantable Collamer Lens), which is an alternative to LASIK and other refractive procedures. The company operates globally with a focus on vision correction procedures.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 27, 2024 | $88.59m | $82.91m | - | - | 0.00% | 0.00% |
| June 28, 2024 | $99.0m | $87.11m | - | - | 0.00% | 0.00% |
| March 29, 2024 | $77.36m | $79.64m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Staar Surgical Co.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.